´ëÇѽɺÎÀüÇÐȸ 2024 ÇÏ°è ½ÉÆ÷Áö¾ö : 2024-06-15
±³À°ÀÏÀÚ : 2024-06-15
±³À°Àå¼Ò : SCÄÁº¥¼Ç¼¾ÅÍ, ÁöÇÏ1Ãþ ´ëȸÀǽÇ1
±³À°ÁÖÁ¦ : ´ëÇѽɺÎÀüÇÐȸ 2024 ÇÏ°è ½ÉÆ÷Áö¾ö
ÁÖÃÖ±â°ü : ´ëÇѽÉÀåÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѽɺÎÀüÇÐȸ
´ã´çÀÚ : ¹èÀ翬
¿¬¶ôó : 02-3275-5335
À̸ÞÀÏ : kshf3@kshf.or.kr
±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀÎ : 100¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 50ºÐ
¼¼ºÎ¼ö°·á : 50,000¿ø
ºñ°í " - »çÀüµî·Ï : Àü¹®ÀÇ(30,000¿ø) / ÀüÀÓÀÇ, ÀÓ»ó°»ç(10,000¿ø) / Àü°øÀÇ, °£È£»ç, Á¦¾à»ç ±× ¿Ü ÀÇ·áÁ¾»çÀÚ ¹«·á - ÇöÀåµî·Ï: Àü¹®ÀÇ(50,000¿ø) / ÀüÀÓÀÇ, ÀÓ»ó°»ç(20,000¿ø) / Àü°øÀÇ, °£È£»ç, Á¦¾à»ç ±× ¿Ü ÀÇ·áÁ¾»çÀÚ(10,000¿ø)"
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 06¿ù 15ÀÏ ´ëȸÀǽÇ1 09:00~09:20 Role of BNP/NT-proBNP in Heart Failure with Kidney Disease - Do you Believe it? ÇöÁØÈ£(¿ï»êÀÇ´ë)
±³À°½Ã°£ 06¿ù 15ÀÏ ´ëȸÀǽÇ1 09:20~09:40 Role of Troponin in Heart Failure with Kidney Disease - For ACS and more ÀÌÁÖÈñ(ÃæºÏÀÇ´ë)
±³À°½Ã°£ 06¿ù 15ÀÏ ´ëȸÀǽÇ1 09:40~10:00 Role of sST2 and GDF-15 in Heart Failure with Kidney Disease - Any Additive Role? ¹ÚÁøÁÖ(¼¿ïÀÇ´ë)
Åä·Ð 06¿ù 15ÀÏ ´ëȸÀǽÇ1 10:00~10:20 Discussion ±è°æÁø, ±è°æÈñ, ±è¹Î¼®, ¹Ú»ó¹Î, Á¤Çý¹®, ÃÖÁø¿À(ÀÌÈÀÇ´ë, ÀÎõ¼¼Á¾º´¿ø, ¿ï»êÀÇ´ë, À»ÁöÀÇ´ë, °æÈñÀÇ´ë, ¼º±Õ°üÀÇ´ë)
ÈÞ½Ä 06¿ù 15ÀÏ ´ëȸÀǽÇ1 10:20~10:50 Break ()
±³À°½Ã°£ 06¿ù 15ÀÏ ´ëȸÀǽÇ1 10:50~11:10 Echo Imaging in Ischemic Cardiomyopathy: Oldies, but Goodies, Anything New? Á¶µ¿Çõ(°í·ÁÀÇ´ë)
±³À°½Ã°£ 06¿ù 15ÀÏ ´ëȸÀǽÇ1 11:10~11:30 CMR in Ischemic Cardiomyopathy: Essential and One more Thing a Cardiologist Needs to Know ±¸ÇöÁ¤(¿ï»êÀÇ´ë)
±³À°½Ã°£ 06¿ù 15ÀÏ ´ëȸÀǽÇ1 11:30~11:50 Invasive Coronary Physiology in Heart Failure À̽ÂÇå(Àü³²ÀÇ´ë)
Åä·Ð 06¿ù 15ÀÏ ´ëȸÀǽÇ1 11:50~12:10 Discussion °íÃæ¿ø, ¹Ú¼º¹Ì, ¾çÁ¤ÈÆ, Á¤¼ºÈ£, Á¶¾çÇö, ÃÖÀÇ¿µ(ÀÌÈÀÇ´ë, °í·ÁÀÇ´ë, ¼º±Õ°üÀÇ´ë, ¿ï»êÀÇ´ë, ¼º±Õ°üÀÇ´ë, ¿¬¼¼ÀÇ´ë)
ÈÞ½Ä 06¿ù 15ÀÏ ´ëȸÀǽÇ1 12:10~12:20 Break ()
½Ä»ç 06¿ù 15ÀÏ ´ëȸÀǽÇ1 12:20~13:00 Lunch ()
±âŸ 06¿ù 15ÀÏ ´ëȸÀǽÇ1 13:00~13:05 ÀÇ·á»çŸ¦ °ÞÀ¸¸ç ÀþÀº ½ÉºÎÀü Àü¹®ÀǷμ ´À³¢´Â ¼Òȸ ¹è´ëȯ(ÃæºÏÀÇ´ë)
±âŸ 06¿ù 15ÀÏ ´ëȸÀǽÇ1 13:05~13:10 ÀÇ·á»çŸ¦ °ÞÀ¸¸ç º¯ÇÏ´Â °Íµé, ±¦ÂúÀº °É±î? ¹Ú¹ÎÁ¤(¼º±Õ°üÀÇ´ë)
±âŸ 06¿ù 15ÀÏ ´ëȸÀǽÇ1 13:10~13:20 Discussion ¹ÚÀçÇü, À±¹ÎÀç, ÃÖ¼ºÈÆ(Ãæ³²ÀÇ´ë, ¼¿ïÀÇ´ë, ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 06¿ù 15ÀÏ ´ëȸÀǽÇ1 13:20~13:40 Cardiac Sarcoidosis, Updated Diagnosis and Treatment Guide ±èÀÎö(°è¸íÀÇ´ë)
±³À°½Ã°£ 06¿ù 15ÀÏ ´ëȸÀǽÇ1 13:40~14:00 Differential Diagnosis in Amyloidosis, Step by Step Guide ±è´Ù·¡(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 06¿ù 15ÀÏ ´ëȸÀǽÇ1 14:00~14:20 Recent Diagnostic and Therapeutic Strategy of Arrhythmogenic Cardiomyopathy ¿ÀÀç¿ø(¿¬¼¼ÀÇ´ë)
Åä·Ð 06¿ù 15ÀÏ ´ëȸÀǽÇ1 14:20~14:40 Discussion °ø¹Î±Ô, ±èÇüÀ±, ·ùµ¿¿, Á¶À翵, ÃÖÁ¤Çö, Çã¶õ(¼øõÇâÀÇ´ë, °¡ÃµÀÇ´ë, °¿øÀÇ´ë, Àü³²ÀÇ´ë, ºÎ»êÀÇ´ë, ÇѾçÀÇ´ë)
ÈÞ½Ä 06¿ù 15ÀÏ ´ëȸÀǽÇ1 14:40~15:10 Break ()
±³À°½Ã°£ 06¿ù 15ÀÏ ´ëȸÀǽÇ1 15:10~15:30 Practical Use of IV Diuretics in Urgent HF Patients at the Outpatient Clinic À̼±±â(°í·ÁÀÇ´ë)
±³À°½Ã°£ 06¿ù 15ÀÏ ´ëȸÀǽÇ1 15:30~15:50 Real Practice of IV Iron Therapy in the Outpatient Setting À±Á¾Âù(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 06¿ù 15ÀÏ ´ëȸÀǽÇ1 15:50~16:10 Home Monitoring of My HF Patients: Efforts to Improve Outcome ¼ÕÁ¤¿ì(¿¬¼¼¿øÁÖÀÇ´ë)
Åä·Ð 06¿ù 15ÀÏ ´ëȸÀǽÇ1 16:10~16:30 Discussion ±è¹Ì³ª, À̼÷Áø, ÀÌÂùÁÖ, À念¿ì, Á¤¹ÌÇâ, Á¶»óÈ£(°í·ÁÀÇ´ë, Èù¸²ÀÇ´ë, ¿¬¼¼ÀÇ´ë, °¡ÃµÀÇ´ë, °¡Å縯ÀÇ´ë, ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 06¿ù 15ÀÏ ´ëȸÀǽÇ1 16:30~16:50 Desmoplakin Cardiomyopathy: A Cardiocutaneous Syndrome ÇÏ°æÀº(°¡ÃµÀÇ´ë)
±³À°½Ã°£ 06¿ù 15ÀÏ ´ëȸÀǽÇ1 16:50~17:10 IgG4-related Disease Manifesting as Eosinophilic Myopericarditis and Nonbacterial Thrombotic Endocarditis ¹è´ëȯ(ÃæºÏÀÇ´ë)
±³À°½Ã°£ 06¿ù 15ÀÏ ´ëȸÀǽÇ1 17:10~17:30 Challenges in the Diagnosis of the Cardiomyopathy: Learning from Mistake ¾çÅÂÀÏ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 06¿ù 15ÀÏ ´ëȸÀǽÇ1 17:30~17:50 Intractable Coronary Vasospasm in Early Postoperative Heart Transplantation ±è¹ÌÁÖ(Ãæ³²ÀÇ´ë)
Åä·Ð 06¿ù 15ÀÏ ´ëȸÀǽÇ1 17:50~18:00 Discussion ±èÀÀÁÖ, ¹Ú¼ºÁö, ½ÉÁö¿µ, À¯½Â±â, ÀÌ»ó¾ð, Á¶ÇöÀç, Ȳ¼®Àç(°í·ÁÀÇ´ë, ¼º±Õ°üÀÇ´ë, ¿¬¼¼ÀÇ´ë, ÀÌÈÀÇ´ë, ¿ï»êÀÇ´ë, ¼¿ïÀÇ´ë, °æ»óÀÇ´ë)